- Home
- CTXR vs GENK Comparison
CTXR vs GENK Comparison
Compare CTXR & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- GENK
- Stock Information
- Founded
- CTXR 2007
- GENK 2011
- Country
- CTXR United States
- GENK United States
- Employees
- CTXR N/A
- GENK N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- GENK Restaurants
- Sector
- CTXR Health Care
- GENK Consumer Discretionary
- Exchange
- CTXR Nasdaq
- GENK Nasdaq
- Market Cap
- CTXR 18.7M
- GENK 20.4M
- IPO Year
- CTXR N/A
- GENK 2023
- Fundamental
- Price
- CTXR $1.35
- GENK $3.32
- Analyst Decision
- CTXR Strong Buy
- GENK Strong Buy
- Analyst Count
- CTXR 3
- GENK 2
- Target Price
- CTXR $53.00
- GENK $7.00
- AVG Volume (30 Days)
- CTXR 360.0K
- GENK 74.2K
- Earning Date
- CTXR 08-12-2025
- GENK 08-06-2025
- Dividend Yield
- CTXR N/A
- GENK 3.77%
- EPS Growth
- CTXR N/A
- GENK N/A
- EPS
- CTXR N/A
- GENK N/A
- Revenue
- CTXR N/A
- GENK $216,137,000.00
- Revenue This Year
- CTXR N/A
- GENK $17.79
- Revenue Next Year
- CTXR $851.67
- GENK $15.87
- P/E Ratio
- CTXR N/A
- GENK N/A
- Revenue Growth
- CTXR N/A
- GENK 10.67
- 52 Week Low
- CTXR $0.65
- GENK $3.15
- 52 Week High
- CTXR $17.00
- GENK $10.33
- Technical
- Relative Strength Index (RSI)
- CTXR 49.89
- GENK 38.21
- Support Level
- CTXR $1.18
- GENK $3.15
- Resistance Level
- CTXR $1.45
- GENK $3.51
- Average True Range (ATR)
- CTXR 0.10
- GENK 0.22
- MACD
- CTXR -0.00
- GENK -0.04
- Stochastic Oscillator
- CTXR 62.96
- GENK 16.83
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.
About GENK GEN Restaurant Group Inc.
GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.